Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
72.77 CAD | -0.01% | +1.80% | +25.12% |
15/04 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
12/04 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.33% | 306B | |
+11.83% | 153B | |
+52.00% | 124B | |
+22.58% | 83.43B | |
+12.58% | 78.06B | |
+21.46% | 62.81B | |
+14.20% | 60.08B | |
+13.01% | 49.91B | |
+33.13% | 37.05B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Insider Trends: Insider Buying Continued with Purchase of Ovintiv Stock